OClawVPS.com
QIAGEN
Edit

QIAGEN

http://www.qiagen.com/
Last activity: 18.12.2025
Active
Categories: BioTechBuildingContentDataDiagnosticsHealthTechLifePagePersonalProvider
Links to websites are provided for convenience and do not imply sponsorship, affiliation or endorsement.


Guidelines when using our Facebook page

We ask that you please adhere to the following guidelines when using our Facebook page:

1. Netiquette

Posting and commenting on our Facebook page should follow these general communications rules:

• Treating all other users as you would like to be treated by them
• Respecting the opinions of others and not trying to force your opinion on anyone else. Everyone has the right to express their own opinion
• Respecting the rights of others

2. Deletion of posts/comments and blocking Facebook accounts

The following actions are examples that are seen as violations of the terms of use. These actions will result in the immediate deletion of posts/comments or, in the case of gross or repeated violations, we will block the user so that he or she is not able to post further content or comments on our page:

• Personal insults or degrading comments of any kind
• Defamatory, anti-constitutional, racist, or pornographic statements or illustrations
• Disparaging comments about institutions, organizations or companies, sexist or racist comments, or hate propaganda
• Any violation of the rights of third parties, in particular copyrights
• Comments that do not relate to the messages under discussion or that are off-topic
• Attacking others or calling for violence of any kind
• Calls to join in demonstrations or rallies of any political orientation
• Offering goods or services, of either a commercial or private nature, or using this Facebook page as an advertising space
• Spam, i.e., any form of automatically generated content or repeatedly posting the same comment

3. Privacy policy

We created this Facebook page in order to connect and facilitate with interested people an exchange about science, biotechnology, healthcare, molecular diagnostics, and other QIAGEN-related topics. The Privacy Policy covers how we handle personal data, which is submitted to Facebook by clicking the “Like” button on our Facebook page. This data is also accessible to QIAGEN. The data we receive from Facebook contains:

• Age demographics
• Place of residence (country and city)
• Gender
• Language
• Activity statistics/rate of all people using our page

Facebook provides this data exclusively in a summarized form. QIAGEN does not receive data on individuals or small user groups. We don’t share the data with third parties. User data is used exclusively to administer our Facebook page and to learn more about which topics are of interest to our followers so that we can further improve our page’s offering.

4. Disclaimer

The messages posted in response to our articles reflect the opinions of individual members only. We are not liable for the content of any messages, or for conclusions that may be drawn from such messages. QIAGEN makes no representations or warranties of any kind about the accuracy or completeness of the content.
Likes
52.29K
Followers
170.05K
Website visits
598.9K /mo.
Mentions
102
Location: Germany, North Rhine-Westphalia, Hilden
Employees: 5001-10000
Phone: +49 2103 290
Total raised: $100M
Founded date: 1984

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
12.07.2021-$100M-

Mentions in press and media 102

DateTitleDescription
18.12.2025Bringing rapid, lab-grade diagnostics to the pond side-
14.10.2025CONEXEN launches Manchester community to further strengthen life sciences ecosystem connections beyond the golden triangleCONEXEN (Connect – Exchange – Engage), the award-winning life sciences ecosystem activator, announces the launch of its Manchester community on October 23rd, extending its reach beyond the Cambridge-Oxford-London corridor to support and con...
02.10.2025Neo4j investe US$ 100 milhões em GenAI e lança soluções para agentes de IAA Neo4j anunciou um investimento de US$ 100 milhões destinado a acelerar sua presença como infraestrutura crítica para inteligência artificial generativa (GenAI) e como camada de conhecimento para sistemas baseados em agentes de IA. O aport...
13.05.2025QIAGEN Enhances Leading Clinical Genomics Portfolio With Acquisition of Genoox AI-powered SoftwareAcquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use, fast and flexible NGS d...
19.03.2025Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbHIRVINE, Calif., March 19, 2025 /PRNewswire/ -- Zymo Research Corporation acknowledges the recent ruling, on March 14, 2025, by the United States District Court for the Central District of California in the ongoing litigation with QIAGEN Gmb...
18.03.2025MarTech Interview with Umer Paracha, Head of Marketing at TopsortUmer, you’ve had a fascinating career path that spans across ecommerce, retail, and D2C brands. Could you walk us through your professional journey so far, and what you’re most passionate about in your work? My career has been an exciting j...
02.12.2024AdvantageClub.ai raises $4 Million from Axilor Ventures to expand in the US and Asia and add New Product LinesMANILA, Philippines, Dec. 2, 2024 /PRNewswire/ -- AdvantageClub.ai, a leader in employee engagement solutions, has raised $4 million in its latest funding round, bringing its total funding to $11 million. The round was led by Axilor Venture...
27.11.2024QIAGEN führt neuartige Tools zur Anpassung von digitalen PCR‑Assays und NGS-Panels für die mikrobielle Analyse einQIAGEN führt das erste Design-Tool für individuell anpassbare digitale PCR-Assays im Markt ein, ausgestattet mit fortschrittlichen Design-Algorithmen für verschiedene mikrobielle Anwendungen und kundenspezifische NGS-Panels // Erstes Custom...
27.11.2024QIAGEN führt neuartige Tools zur Anpassung von digitalen PCR‑Assays und NGS-Panels für die mikrobielle Analyse einVENLO, Niederlande, Nov. 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung von zwei neuen Werkzeugen für die Entwicklung und Bestellung von individuell anpassbaren Lösungen bekannt gege...
13.11.2024Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle InnovationIRVINE, Calif., Nov. 13, 2024 /PRNewswire/ -- Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District Court for the Central District of Califo...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In